Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL164352 | 0.94 | ALDH1A1 (0.40) | ALDH1A1HSD17B10HIF1ACYP1B1KMT2A | |
| SCHEMBL29663893 | 0.94 | ALDH1A1 (0.40) | ALDH1A1HSD17B10HIF1ACYP1B1KMT2A | |
| SCHEMBL29634291 | 0.93 | ALDH1A1 (0.39) | ALDH1A1HSD17B10HIF1ACYP1B1KMT2A | |
| SCHEMBL160528 | 0.93 | ALDH1A1 (0.39) | ALDH1A1HSD17B10HIF1ACYP1B1KMT2A | |
| SCHEMBL23803978 | 0.80 | AHR (0.41) | ALDH1A1HSD17B10KMT2APOLBESR1 | |
| SCHEMBL6201679 | 0.79 | CYP1A2 (0.46) | ALDH1A1HSD17B10HIF1ACYP1B1KMT2A | |
| SCHEMBL6206954 | 0.76 | TNKS (0.37) | ALDH1A1HSD17B10HIF1ACYP1B1KMT2A | |
| SCHEMBL30476322 | 0.76 | CYP1A2 (0.46) | ALDH1A1HSD17B10HIF1ACYP1B1KMT2A | |
| SCHEMBL1309270 | 0.76 | ALDH1A1 (0.50) | ALDH1A1HSD17B10HIF1ACYP1B1KMT2A | |
| SCHEMBL28763218 | 0.73 | HPRT1 (0.44) | ALDH1A1HSD17B10HIF1ACYP1B1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2370420-A1 | PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL, INC. (US) | 2011-10-05 | — | — | EP | claimed |
| WO-2010065393-A1 | PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL, INC. (US) | 2010-06-10 | — | — | WO | claimed |
| US-20090309076-A1 | PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL, INC. (US) | 2009-12-17 | — | — | US | claimed |
| US-20180291008-A1 | Photochromic Compounds | TRANSITIONS OPTICAL, INC. | 2018-10-11 | — | — | US | disclosed |
| US-20180291007-A1 | Photochromic Compounds | TRANSITIONS OPTICAL, INC. | 2018-10-11 | — | — | US | disclosed |
| US-20180291009-A1 | Photochromic Compounds | TRANSITIONS OPTICAL, INC. | 2018-10-11 | — | — | US | disclosed |
| US-10005763-B2 | Photochromic compounds | TRANSITIONS OPTICAL, INC. (US) | 2018-06-26 | — | — | US | disclosed |
| US-10000472-B2 | Photochromic compounds | TRANSITIONS OPTICAL, INC. (US) | 2018-06-19 | — | — | US | disclosed |
| US-20160333262-A1 | Photochromic Compounds | TRANSITIONS OPTICAL, INC. | 2016-11-17 | — | — | US | disclosed |
| US-20160332995-A1 | Photochromic Comounds | TRANSITIONS OPTICAL, INC. | 2016-11-17 | — | — | US | disclosed |
| US-9405041-B2 | Photochromic compounds | TRANSITIONS OPTICAL, INC. (US) | 2016-08-02 | — | — | US | disclosed |
| US-8211338-B2 | Photochromic compounds | TRANSITIONS OPTICAL, INC (US) | 2012-07-03 | — | — | US | disclosed |
| US-20120145975-A1 | PHOTOCHROMIC MATERIALS HAVING EXTENDED PI-CONJUGATED SYSTEMS AND COMPOSITIONS AND ARTICLES INCLUDING THE SAME | TRANSITIONS OPTICAL, INC. (US) | 2012-06-14 | — | — | US | disclosed |
| US-20120053341-A1 | PHOTOCHROMIC MATERIALS THAT INCLUDE 6-AMINO SUBSTITUTED INDENO-FUSED NAPHTHOPYRANS | TRANSITIONS OPTICAL, INC. (US) | 2012-03-01 | — | — | US | disclosed |
| EP-2370420-A1 | PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL, INC. (US) | 2011-10-05 | — | — | EP | disclosed |
| WO-2010065393-A1 | PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL, INC. (US) | 2010-06-10 | — | — | WO | disclosed |
| US-20090309076-A1 | PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL, INC. (US) | 2009-12-17 | — | — | US | disclosed |
| EP-1360183-B1 | NOVEL PHOTOCHROMIC INDENONAPHTHOPYRAN COMPOUNDS | TRANSITIONS OPTICAL INC (US) | 2005-08-17 | — | — | EP | disclosed |
| US-6736998-B2 | INDENONAPHTHOPYRAN COMPOUNDS WHEN EXPOSED TO LIGHT RADIATION CONTAINING ULTRAVIOLET RAYS EXHIBIT A REVERSIBLE CHANGE IN COLOR; LENSES AND OPHTHALMIC LENSES | TRANSITIONS OPTICAL, INC. | 2004-05-18 | — | — | US | disclosed |
| US-20030071247-A1 | Novel indeno-fused photochromic naphthopyrans | TRANSITIONS OPTICAL LIMITED (IE) | 2003-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180291007-A1 | Photochromic Compounds | CCR4, CCR8, CBR3 | ALDH1A1 1805/4885HSD17B10 2051/4885HIF1A 3948/4885 |
| US-20160332995-A1 | Photochromic Comounds | CCR4, CCR3, CCR8 | ALDH1A1 1767/4885HSD17B10 1730/4885HIF1A 3583/4885 |
| US-10005763-B2 | Photochromic compounds | CCR4, CCR8, CBR3 | ALDH1A1 1782/4885HSD17B10 2023/4885HIF1A 3941/4885 |
| US-20180291008-A1 | Photochromic Compounds | CCR4, CBR3, CCR8 | ALDH1A1 1817/4885HSD17B10 1708/4885HIF1A 3772/4885 |
| US-20120145975-A1 | PHOTOCHROMIC MATERIALS HAVING EXTENDED PI-CONJUGATED SYSTEMS AND COMPOSITIONS AND ARTICLES INCLUDING THE SAME | IPO4, INTS6, INCENP | ALDH1A1 1027/4885HSD17B10 2360/4885HIF1A 3771/4885 |
| US-20160333262-A1 | Photochromic Compounds | CCR4, CCR8, CBR3 | ALDH1A1 1782/4885HSD17B10 2023/4885HIF1A 3941/4885 |
| US-20180291009-A1 | Photochromic Compounds | CCR4, CCR8, CBR3 | ALDH1A1 1831/4885HSD17B10 2055/4885HIF1A 3980/4885 |
| US-10000472-B2 | Photochromic compounds | CCR4, CCR8, CBR3 | ALDH1A1 1782/4885HSD17B10 2023/4885HIF1A 3941/4885 |
| US-20120053341-A1 | PHOTOCHROMIC MATERIALS THAT INCLUDE 6-AMINO SUBSTITUTED INDENO-FUSED NAPHTHOPYRANS | MITF, NPEPPS, GNE | ALDH1A1 1282/4885HSD17B10 4576/4885HIF1A 2784/4885 |
| US-20090309076-A1 | PHOTOCHROMIC COMPOUNDS | CCR4, CCR8, CBR3 | ALDH1A1 1782/4885HSD17B10 2023/4885HIF1A 3941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.